Skip to main content
. 2017 Feb 22;55(3):884–892. doi: 10.1128/JCM.02010-16

FIG 1.

FIG 1

Pretreatment levels of IgA antibody toward GPL core components in the entire study population and three subgroups based on treatment outcomes (the culture conversion, recurrence, and nonconversion groups). All results are expressed as individual data; horizontal bars indicate the medians and interquartile ranges. The P value was calculated by using the Kruskal-Wallis test.